Corrigendum to “Harnessing Nur77's mitochondrial apoptotic pathway: A promising therapeutic strategy for targeted disease intervention” [Biomed. Pharmacother. 187 (2025) 118091] - 10/06/25
Doi : 10.1016/j.biopha.2025.118230
Ruihai Fu a, Dandan Ling b, c, Qiqi Zhang a, Aifang Jiang a, d, Haiyan Pang a, d, ⁎ 
a Department of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, PR China
b Clinical Research Center for Placental Medicine in Hunan Province, Changsha City, Hunan Province, PR China
c Department of Obstetrics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha City, Hunan Province, PR China
d School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong Province, PR China
⁎Corresponding author at: Department of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, PR ChinaDepartment of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical UniversityWeifangShandong ProvincePR China
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Tuesday 10 June 2025
Le texte complet de cet article est disponible en PDF.
© 2025
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?